🟢 20/20 Biolabs is trading 12.9% up in pre-market as major index futures rise

20/20 Biolabs is trading 12.88% up now at $0.61, likely reflecting broader risk-on sentiment.

• Rebounding from the September 10 close of $0.54.
• No fresh company-specific announcement explaining the September 11 pre-market rise was identified; latest filing coverage remains focused on Nasdaq compliance issues and an earlier investor webinar.
• S&P 500, Nasdaq Composite, and Dow futures are each up more than 0.5%.